Medpace Holdings, Inc. to Report Second Quarter 2018 Financial Results on July 30, 2018

16:05 EDT 11 Jul 2018 | Businesswire

This article has expired, however you can still download the PDF.
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2018 financial results after the market close on Monday, July 30, 2018. The Company will host a conference call the fol...

Other Sources for this Article

Medpace Holdings, Inc.
Julie Hopkins, 513-579-9911 x12627
Investor Contact:


More From BioPortfolio on "Medpace Holdings, Inc. to Report Second Quarter 2018 Financial Results on July 30, 2018"

Quick Search


Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...